Spots Global Cancer Trial Database for Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
Official Title: Study on Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
Study ID: NCT04974424
Interventions
Study Description
Brief Summary: Most uterine cervical high-risk human papillomavirus (HPV) infections are transient, with only a small fraction developing into cervical cancer. Family aggregation studies and heritability estimates suggest a significant inherited genetic component. Candidate gene studies and previous genome-wide association studies (GWASs) report associations between the HLA region and cervical cancer. Adopting a genome-wide approach, we aimed to establish an early warning model for a high-risk population of cervical cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 25 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Tongji Hospital, Wuhan, Hubei, China
Contact Details
Name: Ding Ma, MD, PhD
Affiliation: Huazhong University of Science and Technology
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
